Pro Medicus (OTCMKTS:PMCUF - Get Free Report) and DarioHealth (NASDAQ: DRIO - Get Free Report) are b

Phreesia (NYSE: PHR - Get Free Report) and DarioHealth (NASDAQ: DRIO - Get Free Report) are both sma

Alliance Global Partners analyst Scott Henry initiates coverage on DarioHealth (NASDAQ:DRIO) with

TD Cowen analyst Charles Rhyee maintains DarioHealth (NASDAQ:DRIO) with a Hold and lowers the pri

DarioHealth Corp. (DRIO) Q2 2026 Earnings Call Transcript

DarioHealth NASDAQ: DRIO reported second-quarter 2026 revenue of $5.2 million, down from $5.6 millio

DarioHealth Corp. (DRIO) came out with a quarterly loss of $0.57 per share versus the Zacks Consensu

DarioHealth (NASDAQ:DRIO) reported quarterly losses of $(0.72) per share which beat the analyst cons

Second quarter 2026 revenue was $5.2 million, reflecting the Company's strategic decision to discont

New programs, expected to begin revenue contribution Q4 2026, extend Dario's integrated healthcare p

Company to host conference call and webcast at 8:30 a.m. Eastern Time NEW YORK, Aug. 3, 2026 /PRNews

First commercial offering from Dario's collaboration with Beluga Health adds licensed provider e

First commercial offering from Dario's collaboration with Beluga Health adds licensed provider evalu

DarioHealth (DRIO) witnessed a jump in share price last session on above-average trading volume. The

A member of the Company's Board of Directors participated in the Offering by purchasing 14,430 s

The financing was led by continued support of existing long-term institutional investors along with

DarioHealth (NASDAQ: DRIO - Get Free Report) and Echo Therapeutics (OTCMKTS:ECTE - Get Free Report)

DarioHealth Corp. (NASDAQ:DRIO) (the "Company", "DarioHealth" or "Dario"), a

Contract award for over 100,000 eligible employees marks Dario's fifth Fortune 50 client, further re

DarioIQ drives higher engagement and retention, better clinical outcomes, higher client ROI and recu

This opportunity makes Dario's cardiometabolic solution available to the insurer's Administr

Agreement representative of Dario's channel-led growth strategy to bring cardiometabolic digital hea

Top National Health Plan Extends Agreement for Mental Health and Expands Dario Partnership into Card

The expansion follows success with Dario's behavioral health offering. The health plan's rol

Third health plan customer to expand beyond initial deployment, reinforcing Dario's land-and-expand

O'Reilly's extensive experience across healthcare compliance, risk management, regulatory oversight

By combining Dario's multi-condition engagement offering with Beluga's physician-led, 50-sta

Dario's best-in-class, consumer-centric chronic care platform, combined now with Beluga's embedded c

DarioHealth (DRIO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the

DarioHealth (NASDAQ:DRIO) reported quarterly losses of $(0.95) per share which beat the analyst cons

Findings highlight the role of continuous behavioral support in improving focus, productivity and da

DarioHealth (NASDAQ:DRIO) reported quarterly losses of $(0.82) per share, which is a 2.12 percent de

DarioHealth (NASDAQ:DRIO) reported quarterly sales of $5.200 million which beat the analyst consensu

Findings reinforce that engagement data provide clinical signals directly impacting ROIAnalysis furt

As oral GLP-1s enter the market with slightly more modest weight and glycemic outcomes than injectab

Peer-reviewed JMIR Cardio study demonstrates real-world clinical impact of data-driven digital nudge

Sanofi and Symphony Health teams conducted the study demonstrating how Dario's digital, diabetes

DarioHealth (NASDAQ:DRIO) reported quarterly losses of $(1.91) per share which beat the analyst cons

New clients span multiple industries and underscore broad increasing demand for Dario's multi-co

The parties have signed a Memorandum of Understanding ("MOU") and expect to conclude a Maste

Two under-the-radar health-tech stocks are seeing their Momentum scores surge in Benzinga's Edge

Gainers bioAffinity Technologies (NASDAQ: BIAF) stock increased by 71.8% to $5.86 during Friday&#39

U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Friday.